行情

VCYT

VCYT

Veracyte
NASDAQ

实时行情|Nasdaq Last Sale

28.46
-0.72
-2.47%
已收盘, 18:55 12/09 EST
开盘
29.00
昨收
29.18
最高
29.34
最低
28.27
成交量
36.49万
成交额
--
52周最高
31.18
52周最低
10.72
市值
13.90亿
市盈率(TTM)
-147.9210
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

VCYT 新闻

  • Did Business Growth Power Veracyte's (NASDAQ:VCYT) Share Price Gain of 255%?
  • Simply Wall St..5天前
  • NanoString announces exclusive license of nCounter Diagnostic assets to Veracyte
  • Seeking Alpha - Article.5天前
  • The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug
  • Benzinga.5天前
  • The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug
  • Benzinga.5天前

更多

所属板块

生物技术和医学研究
+0.51%
制药与医学研究
+0.23%

热门股票

名称
价格
涨跌幅

VCYT 简况

Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.
展开

Webull提供Veracyte Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。